SCHEMBL5136323

SCHEMBL5136323

Cc1c(-c2ccnc(N(c3ccccc3)c3cccc(S(=O)(=O)NCc4ccccc4)c3)n2)sc(=O)n1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 3/20 0.47
CLK1 P49759 1/20 0.47
ALDH1A1 P00352 2/20 0.41
PKM P14618 1/20 0.41
MKNK2 Q9HBH9 3/20 0.39
BRD4 O60885 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
RECQL P46063 1/20 0.38
TSHR P16473 1/20 0.37
LMNA P02545 2/20 0.36
POLB P06746 2/20 0.36
KEAP1 Q14145 1/20 0.36
CCNT1 O60563 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5136327 0.87 ALDH1A1 (0.41) CDK2CLK1ALDH1A1PKMBRD4
SCHEMBL2085458 0.83 CDK2 (0.55) CDK2CLK1ALDH1A1PKMMKNK2
SCHEMBL2086771 0.78 CDK2 (0.58) CDK2CLK1MKNK2CCNT1CDK7
SCHEMBL27664540 0.75 CDK2 (0.51) CDK2CLK1ALDH1A1MKNK2TSHR
SCHEMBL2086251 0.74 CDK2 (0.54) CDK2CLK1MKNK2CCNT1CDK7
SCHEMBL2086940 0.71 CDK2 (0.51) CDK2CLK1MKNK2CCNT1CDK7
SCHEMBL2086822 0.70 CDK2 (0.59) CDK2CLK1MKNK2CCNT1CDK7
SCHEMBL27684108 0.70 CDK2 (0.54) CDK2CLK1MKNK2CCNT1CDK7
SCHEMBL2087333 0.69 CDK2 (0.55) CDK2CLK1MKNK2CCNT1CDK7
SCHEMBL2086222 0.69 CDK2 (0.56) CDK2CLK1MKNK2CCNT1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951307-A2 COMBINATION OF A CDK-INHIBITOR AND A HDAC-INHIBITOR Cyclacel Limited (GB) 2008-08-06 EP claimed
WO-2007054725-A2 COMBINATION OF A CDK-INHIBITOR AND A HDAC-INHIBITOR CYCLACEL LIMITED (GB) 2007-05-18 WO claimed